Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neurochemistry

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.2000.0741008.xPMID 10693931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.

  1999cited by this paper
• Inhibition of Cholesterol Production but Not of Nonsterol Isoprenoid Products Induces Neuronal Cell Death

  1999cited by this paper
• Differential Generation of High‐Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes

  1999cited by this paper
• Apolipoprotein E4 isoform-specific actions on neuronal cells in culture.

  1999cited by this paper
• Nascent Astrocyte Particles Differ from Lipoproteins in CSF

  1998cited by this paper
• Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis

  1998cited by this paper
• Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

  1998cited by this paper
• Apolipoprotein-mediated cellular cholesterol efflux.

  1998influential reference
• Differential Cellular Accumulation/Retention of Apolipoprotein E Mediated by Cell Surface Heparan Sulfate Proteoglycans

  1998cited by this paper
• Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux.

  1997cited by this paper
• Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.

  1997cited by this paper
• Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

  1997cited by this paper
• Heparan Sulfate Proteoglycans Participate in Hepatic Lipaseand Apolipoprotein E-mediated Binding and Uptake of Plasma Lipoproteins, Including High Density Lipoproteins*

  1997cited by this paper
• Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion.

  1997cited by this paper
• Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site (*)

  1996cited by this paper
• Cyclic AMP Induces Apolipoprotein E Binding Activity and Promotes Cholesterol Efflux from a Macrophage Cell Line to Apolipoprotein Acceptors*

  1996cited by this paper
• Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.

  1996cited by this paper
• Apolipoprotein E Produced by Human Monocyte-derived Macrophages Mediates Cholesterol Efflux That Occurs in the Absence of Added Cholesterol Acceptors*

  1996cited by this paper
• Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux.

  1995cited by this paper
• Monensin and Brefeldin A Inhibit High Density Lipoprotein- mediated Cholesterol Efflux from Cholesterol-enriched Cells

  1995cited by this paper
• Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*)

  1995cited by this paper
• Independent Regulation of Cholesterol Incorporation into Free Apolipoprotein-mediated Cellular Lipid Efflux in Rat Vascular Smooth Muscle Cells (*)

  1995influential reference
• Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line.

  1995cited by this paper
• Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.

  1994cited by this paper
• Apolipoprotein E: structure-function relationships.

  1994cited by this paper
• Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux.

  1994cited by this paper
• A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

  1994cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells.

  1993cited by this paper
• Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells.

  1993cited by this paper
• Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.

  1993cited by this paper
• Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles.

  1993cited by this paper
• Apolipoprotein E polymorphism and Alzheimer's disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway.

  1992cited by this paper
• Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.

  1992cited by this paper
• α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux

  1992cited by this paper
• Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

  1991influential reference
• cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages.

  1991cited by this paper
• Cholesterol transport between cells and high-density lipoproteins.

  1991cited by this paper
• Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol.

  1991cited by this paper
• Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane.

  1990cited by this paper
• Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation.

  1990cited by this paper
• Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

  1988cited by this paper
• Radiation inactivation of binding sites for high density lipoproteins in human fibroblast membranes.

  1988cited by this paper
• Cholesterol flux between cells and high density lipoprotein. Lack of relationship to specific binding of the lipoprotein to the cell surface.

  1987cited by this paper
• Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

  1987cited by this paper
• Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization.

  1987cited by this paper
• Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages.

  1983cited by this paper
• Apolipoproteins in human cerebrospinal fluid.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970influential reference

• Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation.

  2026cites this paper
• Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers

  2025cites this paper
• High-density lipoprotein mimetic peptide 4F ameliorates APOE4-associated lipid dysfunction in primary and iPSC-derived astrocytes and cerebral organoids

  2025cites this paper
• Deletion of neuronal Idol ameliorates Alzheimer's disease–related pathologies via APOE receptors

  2025cites this paper
• Neural Metabolic Networks: Key Elements of Healthy Brain Function

  2025cites this paper
• Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis

  2025cites this paper
• Multi-functional role of apolipoprotein E in neurodegenerative diseases

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure

  2025cites this paper
• Differential Effects of Aβ Peptides on the Plasmin-Dependent Degradation of ApoE3 and ApoE4.

  2025cites this paper
• Discovery of Small Molecule Glycolytic Stimulants for Enhanced ApoE Lipidation in Alzheimer’s Disease Cell Model

  2024cites this paper
• The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects

  2024cites this paper
• Cholesterol Metabolism in Neurodegenerative Diseases

  2024cites this paper
• Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.

  2024cites this paper
• Association between abnormal lipid metabolism and Alzheimer's disease: New research has revealed significant findings on the APOE4 genotype in microglia.

  2024cites this paper
• Identifying pathogenic variants associated with Alzeimer by integrating genomic databases and bioinformatics approaches

  2024cites this paper
• New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease

  2024cites this paper
• A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease

  2024cites this paper
• Updates in Alzheimer's disease: from basic research to diagnosis and therapies

  2024cites this paper
• Role of APOE in glaucoma.

  2023cites this paper
• Unique genetic architecture of CSF and brain metabolites pinpoints the novel targets for the traits of human wellness

  2023cites this paper
• Resveratrol Attenuates the Disruption of Lipid Metabolism Observed in Amyloid Precursor Protein/Presenilin 1 Mouse Brains and Cultured Primary Neurons Exposed to A b

  2023cites this paper
• An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele

  2023cites this paper
• Increased neurotoxicity of high‐density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very‐long‐chain fatty acid transporter Abcd1

  2023cites this paper
• Apolipoprotein E in lipid metabolism and neurodegenerative disease.

  2023cites this paper
• Chemically-Induced Lipoprotein Breakdown for Improved Extracellular Vesicle Purification.

  2023cites this paper
• Astrocyte‐derived lactoferrin reduces β‐amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice

  2023influential citation
• Resveratrol Attenuates the Disruption of Lipid Metabolism Observed in APP/PS1 Mouse Brains and Cultured Primary Neurons Exposed to Aβ.

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell‐type lipidomics

  2022cites this paper
• Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

  2022cites this paper
• A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

  2022cites this paper
• Lipoproteins in the Central Nervous System: From Biology to Pathobiology.

  2022cites this paper
• ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

  2022cites this paper
• Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.

  2022cites this paper
• Isoform- and cell-state-specific lipidation of ApoE in astrocytes.

  2022cites this paper
• ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.

  2022cites this paper
• The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis

  2022cites this paper
• Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis

  2022cites this paper
• Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

  2022cites this paper
• Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease

  2022cites this paper
• Differential associations between apolipoprotein E alleles and cerebral myelin content in normative aging

  2022cites this paper
• The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease

  2022cites this paper
• Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon?

  2021cites this paper
• Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects

  2021cites this paper
• EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL CORD INJURY

  2021cites this paper
• Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.

  2021cites this paper
• Cholesterol Regulates Exosome Release in Cultured Astrocytes

  2021cites this paper
• Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging

  2021cites this paper
• Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

  2021cites this paper
• ApoE and ApoE Nascent-Like HDL Particles at Model Cellular Membranes: Effect of Protein Isoform and Membrane Composition

  2021cites this paper
• Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease

  2020cites this paper
• Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer’s Disease Cooperative Study-Sponsored DHA Clinical Trial

  2020cites this paper
• FASN-Dependent Lipid Metabolism Links Neurogenic Stem/Progenitor Cell Activity to Learning and Memory Deficits.

  2020cites this paper
• APOE in the normal brain.

  2020cites this paper
• Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance

  2020cites this paper
• Dietary Lactoferrin Supplementation Prevents Memory Impairment and Reduces Amyloid-β Generation in J20 Mice

  2020cites this paper
• APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease

  2020influential citation
• Altered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease

  2020cites this paper
• Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E

  2020cites this paper
• Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

  2019cites this paper
• Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

  2019cites this paper
• New APOE-related therapeutic options for Alzheimer’s disease

  2019cites this paper
• Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study

  2019influential citation
• Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.

  2019cites this paper
• Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases

  2019cites this paper
• Ü M W Interaction of amyloid precursor protein and lipid metabolism with relevance to Alzheimer's disease

  2018cites this paper
• The relationship between cholesterol level and Alzheimer’s disease-associated APP proteolysis/Aβ metabolism

  2018cites this paper
• Apolipoprotein E4 genotype compromises brain exosome production

  2018cites this paper
• Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome

  2018cites this paper
• Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice

  2018cites this paper
• The role of APOE on lipid homeostasis and inflammation in normal brains

  2017cites this paper
• NUCLEAR RECEPTORS AS THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE

  2017cites this paper
• Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein

  2017cites this paper
• Brief Literature Review on the Mechanisms Involved in Producing Axial Difussion Injury

  2017cites this paper
• Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE.

  2017cites this paper
• Lysophosphatidylcholine export by human ABCA7.

  2017cites this paper
• Cellular cholesterol homeostasis and Alzheimer’s disease

  2017cites this paper
• Brain cholesterol and the role of statins in neuroprotection

  2016cites this paper
• Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins

  2016cites this paper
• ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies

  2016cites this paper
• The Effect of a High-Fat Diet on Brain Plasticity, Inflammation and Cognition in Female ApoE4-Knockin and ApoE-Knockout Mice

  2016cites this paper
• Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease

  2016cites this paper
• Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging

  2016cites this paper
• The Proteolysis of Apolipoprotein E in Alzheimer's Disease

  2016cites this paper
• Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid

  2016cites this paper
• The role of hypertension and inflammation on the cognitive symptoms of Alzheimer's disease patients

  2016cites this paper
• Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

  2016cites this paper
• Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke

  2015cites this paper
• Nourishing the brain from cradle to grave: The role of nutrients in neural development and neurodegeneration

  2015cites this paper
• Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

  2015cites this paper
• Chandipura virus perturbs cholesterol homeostasis leading to neuronal apoptosis

  2015cites this paper
• Is apolipoprotein E4 an important risk factor for vascular dementia?

  2014cites this paper
• Réorganisations synaptiques dans l'hippocampe et récupération fonctionnelle après lésion du cortex entorhinal : effets de l'allèle APOE4, du bourgeonnement cholinergique et de la réinnervation glutamatergique

  2014cites this paper
• Implication du récepteur LSR (lipolysis stimulated lipoprotein receptor) dans le contrôle de l’homéostasie du cholestérol cérébral et les capacités cognitives au cours du vieillissement

  2014cites this paper
• Prenatal Ethanol Exposure UpRegulates the Cholesterol Transporters ATP-Binding Cassette A 1 and G 1 and Reduces Cholesterol Levels in the Developing Rat Brain

  2014cites this paper
• Review Article APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease

  2014cites this paper
• Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

  2014cites this paper
• APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease

  2014cites this paper
• Influence of APOE genotype and the presence of Alzheimer's pathology on synaptic membrane lipids of human brains

  2014influential citation